Point-of-Care Testing (POCT) Devices Market Size, Share, Growth, and Industry Analysis, By Type (Urinalysis Analyzers, Blood Glucose Meter, Clinical Chemistry Analyzers, Blood Gas Analyzers, INR Test Meter, Cardiac Marker Analyzers, PH Meter, Electrolyte Analyzers & Hemoglobin Meter), By Application (Clinics, Hospitals & Laboratory), and Regional Forecast to 2033

POINT-OF-CARE TESTING (POCT) DEVICES MARKET OVERVIEW

The global Point-of-Care Testing (POCT) Devices Market size was USD 25.67 billion in 2023 and is projected to touch USD 49.29 billion by 2030, exhibiting a CAGR of 9.2% during the forecast period.

The Point-of-Care Testing (POCT) Devices The market is evolving quite fast because of the rising need for fast, precise, and convenient diagnostic tools. These instruments permit medical testing close to the place where medical care is given, and they diminish centralized laboratory testing. The growing need for early diagnosis, increasing chronic diseases, and improvement of technology are the market drivers. The POCT devices are extensively applied within the hospitals, clinics, and home care. The market is likely to grow tremendously with never-ending innovation both in the developed and developing world.

POINT-OF-CARE TESTING (POCT) DEVICES MARKET KEY FINDINGS

Market Size and Growth: The end-user division of clinics bought about 38 % of the revenue share in 2024, representing the expansion of POCT utilization past the traditional hospital-based uses.

Key Market Driver:  In 2023, the global POCT market will be platform-preference driven by the lateral flow assays platform, consisting of 36% revenue share.

Major Market Restraint: Blood glucose monitoring products are dominating the product segment and have a 27 % share of the global POCT devices revenue in 2023.

Emerging Trends: In 2023, North America dominated the global POCT market with a 35.37% market share on account of regional dominance and advanced infrastructure development.

Regional Leadership:  Moreover, the decentralized labs segment will hold the biggest 42.7 percent share in the global POCT molecular diagnostics market in 2023, indicating the decentralization trend.

Competitive Landscape: The current contribution of POCT to the overall in vitro diagnostics market is less than 15 percent, which slows down the overall adoption and incorporation into the healthcare process.

Market Segmentation: Infectious diseases Infectious diseases cause about 30 percent of all deaths worldwide each year, making them a leading indicator of the need to use rapid POCT.

Recent Development: The Global Point-of-Care Testing (POCT) Devices Market size is projected to reach USD 62.491 billion by 2033. The Global Point-of-Care Testing (POCT) Devices Market size was valued at USD 52.405 billion in 2024, with a CAGR of 9.2% during the period of 2025 to 2033.

GLOBAL CRISES IMPACTING POINT-OF-CARE TESTING (POCT) DEVICES MARKET

COVID-19 IMPACT

Point-of-Care Testing (POCT) Devices Industry Had a Positive Effect Due to Pandemic demand during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The point-of-care testing (POCT) devices market was strongly impacted positively by the COVID-19 pandemic as the market grew rapidly and encouraged innovation. Due to the high demand for general, quick, and available testing solutions, the POCT device usage grew worldwide, especially in antigen and antibody testing of COVID-19. Healthcare providers and governments made huge investments in portable diagnostic devices that could help them control the spread of infections and track the health of patients in real time. This demand rush facilitated faster regulatory approval, and manufacturers were urged to increase production. Thus, the POCT market has shown significant growth and become more widely accepted in clinical and non-clinical environments during the pandemic.

LATEST TREND

AI and Connectivity Drive Market Growth in Smarter POCT Devices

Connectivity and AI-driven analytics rapidly integrate into the Point-of-Care Testing (POCT) Devices Market, which becomes one of the most visible trends in the market. Bluetooth, Wi-Fi, and cloud-based devices are now connected in real-time transfer of results to electronic health records and telehealth platforms, allowing remote surveillance of patients and instant clinical intervention. Among them, AI-enhanced diagnostics, e.g., deep-learning chemiluminescence assays of cardiac markers, are approaching, providing POC locations with nearly lab-grade accuracy. This trend does not only enhance the sensitivity and specificity of the test but also provides the opportunity to continuously learn and improve the algorithms as time goes on. Consequently, health professionals are turning more to smarter, connected POCT devices to deliver rapid, more personalized care to patients.

POINT-OF-CARE TESTING (POCT) DEVICES MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into Urinalysis Analyzers, Blood Glucose Meter, Clinical Chemistry Analyzers, Blood Gas Analyzers, INR Test Meter, Cardiac Marker Analyzers, PH Meter, Electrolyte Analyzers & Hemoglobin Meter

Urinalysis Analyzers: Urinalysis analyzers are common point-of-care settings, and they are used in detecting urinary tract infections, kidney disorders, and metabolic disorders. They provide rapid outcomes by analyzing physical, chemical, and microscopic components of urine. These are compact, easy to use, and can be applied in clinics and home care. They are being escalated by rising awareness about regular health check-ups.

Blood Glucose Meter: The blood glucose meters are some of the most common POCT equipment and are commonly used by patients with diabetes. They offer a fast and accurate indication of the level of blood sugar by just pricking the finger. The rising demand for the devices has been hugely enhanced by the rise in the level of diabetes in the world. Constant development is also making them more user-friendly and connected to mobile health apps.

Clinical Chemistry Analyzers: Point-of-Care Clinical chemistry analyzers are devices that are aimed at the measurement of substances like enzymes, electrolytes, and proteins in blood or other bodily fluids. They make the detection and monitoring of conditions like liver and kidney disease easy. The devices have been miniaturized, thereby rendering them useful in near-patient testing. They are expanding in the market because there is a rise in demand for decentralized testing.

Blood Gas Analyzers: Blood gas analyzers are utilized in determining the amount of carbon dioxide, oxygen, and the pH of blood, and they are useful in respiratory and critical care circumstances. They are also significant in making prompt decisions in emergency and ICU situations. Ambulances and field hospitals are taking mobile types. Respiratory problems also contributed to the spreading of the same due to the Covid-19 pandemic.

INR Test Meter: INR test meters are utilized in monitoring the coagulation of the blood of patients who are on anticoagulant treatment. They enable each preferred and regular test without going to the laboratory. The devices assist in the prevention of blood clots and strokes by allowing the proper management of dosages. The increasing incidences of cardiovascular diseases are also making them demanding.

Cardiac Marker Analyzers: Cardiac marker analyzers assist in the identification of the proteins that are discharged on the occasion of heart attacks or other cardiac incidents. They forge diagnoses and prompt treatment in emergency facilities. As the levels of heart disease increase around the world, the analyzers are assuming more crucial roles. Recent developments have made them more sensitive and require less time to get the results.

pH Meter: POCT pH meters are applied in the determination of the acidity or alkalinity of body fluids such as blood and urine. They help in the diagnosis of metabolic or respiratory disturbances. Smaller and battery-powered models are designed to be used on a bedside or remote location. Their application is growing both in hospital and home care. Blood Gas Analyzers: Blood gas analyzers are clinical lab tests that measure the amounts of oxygen, carbon dioxide, and the pH level in blood and help in the treatment of respiratory and critical care situations. They play a very essential role in emergency and ICU situations where fast decisions need to be made. The use of portable models is becoming common in ambulances or field hospitals. Respiratory problems caused by the COVID-19 pandemic only increased their uptake.

Electrolyte Analyzers: Electrolyte analyzers are applied to verify the level of essential electrolytes in blood, including sodium, potassium, and chloride. They are essential readings as far as the preservation of fluid homeostasis, kidney functional ability, and cardiac health are concerned. Portable analyzers to provide a rapid on-site test with minimal sample volume are utilized. They are gaining demand in the emergency and critical care units.

Hemoglobin Meter: A hemoglobin meter is used in screening for anemia depending on the level of hemoglobin in the blood. They are extremely widespread in maternal health programs and in rural health clinics. The gadgets are portable, rapid, and require a small drop of blood. The increase in anemia and nutritional deficiency awareness is increasing their usage.

BY APPLICATION

Based on Application, the global market can be categorized into Clinics, Hospitals & Laboratory

Clinics: POCT devices are also used in clinics to aid in quick and effective diagnosis of a patient when he/she visits the clinic. These tools help in reducing the wait time and make the treatment decisions effective. POCT devices are especially useful when it comes to small or rural clinics, which may be limited in their access to full-scale labs. They are user-friendly and portable, and therefore, applicable in quick testing on the ground.

Hospitals: POCT devices are important to hospitals to get instant diagnostic information, especially in the emergency rooms and in intensive care units. They facilitate prompt actions since they give quick results on important tests such as cardiac markers, blood gases, and glucose levels. POCT can be integrated with hospital information systems to improve efficiency in the workflow. Increasing patient numbers and the demand of patients to receive care quicker are influencing the use of POCT in hospitals.

Laboratory: POCT devices are employed in laboratories as supplementary devices to the conventional, high-throughput analyzers. They are frequently used when the testing is urgent or when it is primary testing to help triage cases ahead of complete lab processing. POCT is also used by some labs to collect samples at remote locations or do testing in the field. Due to decentralization of testing, laboratories are introducing POCT to increase service capacity and scope.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.                          

DRIVING FACTOR

Chronic Diseases and Outbreaks Drive Market Growth Rapidly

Among the various growth drivers of the POCT devices market, the increase in the global chronic disease burden that comprises diabetes, cardiovascular disease, and respiratory diseases is one of the most significant. These conditions should be monitored relatively frequently, so fast and convenient testing methods are essential. POCT devices ensure results in a shorter time, which enables the management of diseases and timely decisions concerning treatment. Moreover, the occurrence of infectious disease outbreaks, e.g., COVID-19, has demonstrated the need to have rapid diagnostic tools at the PoC even more.

Technological Advancements Boost POCT Device Demand and Market Growth Significantly

The constant improvement in the diagnostic technology led to the development of smaller, more accurate, and convenient POCT devices. The said innovations can be tied to mobile apps, cloud-based storage, and EHRs, thus becoming more appealing to healthcare practitioners. They have improved portability and usability, which has augmented their usage in home care, remote, and emergency facilities. As a result, the increase in demand and uptake in various healthcare environments is being prolonged by the technological development and resulting Point-of-Care Testing (POCT) Devices Market growth.

RESTRAINING FACTOR

Lack of Standardization Limits POCT Reliability and Hinders Market Growth

Absence of standardization and comparative accuracy with central laboratory tests is among the key inhibiting factors of the point-of-care testing (POCT) devices market. Variability in results Clinical decision-making can be affected by user error, incorrect handling, or device limitations. This casts a drift in the minds of the medical practitioners on reliance on POCT in critical diagnoses. In this way the barriers to adoption still exist, especially in this high-stakes clinical environment.

OPPORTUNITY

Expanded Rural Healthcare Access Fuels Market Growth Globally

A recent potential of the point-of-care testing (POCT) devices market is the increase of health coverage in remote areas and underserved locations. POCT devices are portable and simple to use, allowing the diagnostics to be taken to places without complete laboratory facilities. This growth is also backed by government programs that encourage healthcare in rural settings and mobile health units. This generates a huge market opportunity in the developing world and low-resource environments.

CHALLENGE

Regulatory Challenges and Quality Concerns Slow Market Growth Adoption

One of the major issues of the point-of-care testing (POCT) devices market is trouble in assuring regulatory standards and controlling quality in varied healthcare facilities. POCT devices are usually used by persons who are not in the laboratory; thus, it is hard to maintain consistency in their accuracy and reliability. It may cause wrong diagnosis or delay of treatment when results are inaccurate. Because of this, the demanding oversight and training needs create hindrances to regular adoption.

POINT-OF-CARE TESTING (POCT) DEVICES MARKET REGIONAL INSIGHTS

●       NORTH AMERICA:

North America Leads Market Growth Through Innovation and Adoption

The point-of-care testing (POCT) devices market is dominated by North America because of superior healthcare facilities, huge healthcare expenditures, and fast uptake of the latest technologies. The area has excellent regulatory backup and early diagnosis and preventive care awareness. It is the headquarters of major players in the industry, which stimulates innovativeness and availability. The United States Point-of-Care Testing (POCT) Devices Market dominates the regional market due to rising demand for rapid diagnostics and chronic disease monitoring. The United States makes the largest contribution in terms of high investment in R\&D and high adoption in hospitals and home care among the North American nations.

●       EUROPE:

Europe Supports Market Growth with Decentralization and Chronic Care

Europe is also a contributor to the point-of-care testing (POCT) devices market because of its focus on decentralized healthcare and early detection of diseases. The area has good government support in the form of diagnostic innovation and home-based testing, particularly in relation to aging populations. Their growing use in the management of chronic disorders and considerable adoption in primary care settings are improving the rate of market growth. Moreover, the European regulatory systems favor the establishment and implementation of dependable and safe POCT devices.

●       ASIA:

Asia Drives Market Growth Through Accessibility, Demand, and Innovation

Asia holds remarkable point-of-care testing (POCT) devices market share due to the rapidly developing healthcare sector and the increased need for available diagnostics. In countries such as China, India, and Japan, the high population base, rising incidences of chronic diseases, and rising awareness regarding early detection are boosting the growth of the market. The rural healthcare support by the government and the use of mobile health also contribute to the rise in the demand for POCT devices. Also, the local production and affordable product development contribute to the fact that Asia is the important area in terms of market expansion.

KEY INDUSTRY PLAYERS

Key Players Drive Market Growth Through Innovation and Accessibility

The influential players in the industry are making huge impacts in the point-of-care testing (POCT) devices market through innovation, product portfolio expansion, and investment in novel diagnostic technologies. Firms, such as Abbott, Roche Diagnostics, Siemens Healthineers, and Danaher, are introducing small, connected, and highly precise gadgets, which suit various medical facilities. The companies also are entering strategic alliances and buying startups to expand their abilities and worldwide presence. They are enhancing clinical decision-making by launching AI-assisted and real-time data-sharing capabilities, which research and development. Also, by concentrating on low prices and convenience, these players are increasing access to the market both in developed and emerging economies.

LIST OF TOP POINT-OF-CARE TESTING (POCT) DEVICES COMPANIES

Abbott (U.S)

Roche Diagnostics (Switzerland)

Medtronic (Ireland)

Johnson & Johnson (U.S)

Siemens Healthineers (Germany)

KEY INDUSTRY DEVELOPMENT

June 2024: A significant industrial development in the POCT sector was the launch of the Atellica VTLi Patient-Side Immunoassay Analyzer by Siemens Healthineers at Katherine Hospital in the Northern Territory of Australia. It is a bedside cardiac troponin testing device that requires a finger prick, with crucial results available in eight minutes as opposed to the typical six-hour lab test, useful in diagnosing heart attacks in distant sites. Such implementation not just echoes the maturity and the real application of high-sensitivity POCT devices but also indicates the industry majors introducing the state-of-the-art diagnostic technology to the under-resourced and regional health setting.

REPORT COVERAGE       

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential Applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.